Free Trial
NASDAQ:EDAP

Edap Tms (EDAP) Stock Price, News & Analysis

$6.12
+0.21 (+3.55%)
(As of 05/24/2024 08:49 PM ET)
Today's Range
$6.00
$6.14
50-Day Range
$5.91
$8.50
52-Week Range
$3.60
$10.32
Volume
10,600 shs
Average Volume
38,132 shs
Market Capitalization
$227.05 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$14.00

Edap Tms MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
128.8% Upside
$14.00 Price Target
Short Interest
Healthy
0.32% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.82mentions of Edap Tms in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.51) to ($0.35) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.16 out of 5 stars

Medical Sector

549th out of 922 stocks

Electromedical Equipment Industry

13th out of 19 stocks

EDAP stock logo

About Edap Tms Stock (NASDAQ:EDAP)

EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST) segments. The HIFU segment develops, manufactures, and markets medical devices based on HIFU technology for the minimally invasive treatment of urological and other clinical indications. This segment also offers Ablatherm, an ultrasound guided robotic HIFU device for the treatment of organ-confined prostate cancer; and the Focal One, a HIFU robotic device dedicated to the focal therapy of prostate cancer, as well as disposables, and leasing and treatment related services; and maintenance services. The ESWL division manufactures, markets, and services lithotripter for the treatment of urinary tract stones by means of ESWL technology; and offers Sonolith i-move, an extracorporeal shockwave lithotripter, as well as sells disposable parts for lithotripters and electrodes. The Distribution division markets, distributes, and services lasers, micro-ultrasound systems, and other medical products from third parties, as well as leases devices; sells disposables and spare parts; and offers maintenance services. It markets and sells its products through its direct marketing, sales organization, and service platform, as well as through third-party distributors and agents. The company serves hospitals, urology clinics, and research institutions. EDAP TMS S.A. was incorporated in 1979 and is based in Lyon, France.

EDAP Stock Price History

EDAP Stock News Headlines

Edap Tms (NASDAQ:EDAP) Rating Reiterated by HC Wainwright
EDAP Reports First Quarter 2024 Financial Results
EDAP TMS S.A. ADR
EDAP TMS S.A. Q4 2023 Earnings Preview
Edap TMS earnings preview: what Wall Street is expecting
See More Headlines
Receive EDAP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Edap Tms and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/27/2024
Today
5/26/2024
Next Earnings (Estimated)
8/22/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Electromedical equipment
Sub-Industry
N/A
Current Symbol
NASDAQ:EDAP
Employees
307
Year Founded
1979

Price Target and Rating

Average Stock Price Target
$14.00
High Stock Price Target
$19.00
Low Stock Price Target
$9.00
Potential Upside/Downside
+128.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$-22,920,000.00
Pretax Margin
-28.95%

Debt

Sales & Book Value

Annual Sales
$65.42 million
Book Value
$1.54 per share

Miscellaneous

Free Float
37,019,000
Market Cap
$227.05 million
Optionable
Optionable
Beta
0.65

Social Links

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Mr. Marc Oczachowski (Age 54)
    Executive Chairman
  • Mr. Ryan Rhodes (Age 62)
    CEO & Director
  • Mr. Ken Mobeck (Age 53)
    Chief Financial Officer
  • Mr. Carre Emmanuel
    Chief Operating Officer
  • Mr. Francois Dietsch (Age 48)
    Chief Accounting Officer
  • Ms. Blandine Confort
    Head of Legal Affairs & Investor Relations and Secretary
  • Mr. Frederic Pech (Age 55)
    President of EDAP TMS France
  • Mr. Jean-Francois Bachelard (Age 60)
    President & Chief Executive Officer of Edaptechnomed Co. Ltd.

EDAP Stock Analysis - Frequently Asked Questions

Should I buy or sell Edap Tms stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Edap Tms in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" EDAP shares.
View EDAP analyst ratings
or view top-rated stocks.

What is Edap Tms' stock price target for 2024?

2 brokerages have issued twelve-month price objectives for Edap Tms' stock. Their EDAP share price targets range from $9.00 to $19.00. On average, they anticipate the company's stock price to reach $14.00 in the next year. This suggests a possible upside of 128.8% from the stock's current price.
View analysts price targets for EDAP
or view top-rated stocks among Wall Street analysts.

How have EDAP shares performed in 2024?

Edap Tms' stock was trading at $5.28 at the start of the year. Since then, EDAP shares have increased by 15.9% and is now trading at $6.12.
View the best growth stocks for 2024 here
.

When is Edap Tms' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 22nd 2024.
View our EDAP earnings forecast
.

How were Edap Tms' earnings last quarter?

Edap Tms S.A. (NASDAQ:EDAP) released its quarterly earnings results on Wednesday, March, 27th. The medical equipment provider reported ($0.15) earnings per share for the quarter, missing analysts' consensus estimates of ($0.02) by $0.13. The medical equipment provider had revenue of $21.27 million for the quarter, compared to analyst estimates of $21.30 million. Edap Tms had a negative trailing twelve-month return on equity of 31.44% and a negative net margin of 30.12%.

What guidance has Edap Tms issued on next quarter's earnings?

Edap Tms updated its FY 2023 earnings guidance on Thursday, February, 29th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $65.4 million-$65.4 million, compared to the consensus revenue estimate of $63.0 million.

What other stocks do shareholders of Edap Tms own?
Who are Edap Tms' major shareholders?

Edap Tms' stock is owned by many different institutional and retail investors. Top institutional investors include Roubaix Capital LLC (0.06%), Miracle Mile Advisors LLC (0.05%) and Virtu Financial LLC (0.03%).

How do I buy shares of Edap Tms?

Shares of EDAP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:EDAP) was last updated on 5/27/2024 by MarketBeat.com Staff

From Our Partners